← Back to Search

Behavioral Intervention

Focused ACT for Depression

N/A
Waitlist Available
Led By Erin Johns, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
no change in psychotropic medication for at least 6 weeks prior to the intervention
willingness to maintain a stable medication type and dose for psychotropic medications during the intervention phase and for one month post-intervention
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6-month follow-up
Awards & highlights

Study Summary

This trial is testing the feasibility and effectiveness of a brief virtual group-based ACT intervention for depression and anxiety delivered in primary care settings.

Eligible Conditions
  • Depression
  • Anxiety
  • Quality of Life
  • Acceptance

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
No change in medication for at least six weeks before the intervention.
Select...
The study participants were willing to take their prescribed medications regularly and to keep the same dose for the entire duration of the study and for one month after the study.
Select...
The text states that self-reported symptoms of depression and/or anxiety are common among medical students.
Select...
The student needs access to reliable internet, a webcam, and a private/quite space to attend sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptance and Action Questionnaire-II
Comprehensive assessment of Acceptance and Commitment Therapy processes
Depression Anxiety and Stress Scale 21-Items
+1 more
Secondary outcome measures
Percentage of planned treatment components delivered during treatment
Treatment Acceptability/Adherence Scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: ACTExperimental Treatment1 Intervention
Focused ACT Group Treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Focused ACT
2022
N/A
~40

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
592 Previous Clinical Trials
199,339 Total Patients Enrolled
16 Trials studying Depression
1,230 Patients Enrolled for Depression
Erin Johns, PhDPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining openings for this research project?

"According to clinicaltrials.gov, this medical trial was initially posted on March 14th 2022 and has since halted recruitment efforts; however, 1554 other trials are actively searching for participants at the moment."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
ACCESS Downtown
ACCESS Winnipeg West
ACCESS Fort Garry
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What state do they live in?
Manitoba

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. ACCESS Downtown: < 48 hours
Average response time
  • < 2 Days
~10 spots leftby Mar 2025